Aktis Oncology Inc.
AKTS | NASDAQ
$15.93
-$0.92 (-5.46%)
At close: Oct 30, 2026, 4:00 PM ET
$15.93
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Net Income | -63.73M | -43.98M | -28.64M | -17.93M |
Depreciation & Amortization | 2.33M | 1.58M | 1.12M | 445K |
Stock-Based Compensation | 5.13M | 2.26M | 1.48M | 698K |
Other Working Capital | -4.22M | 59.48M | -417K | -1.14M |
Other Non-Cash Items | -4.62M | -4.07M | -3.95M | -200K |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | -3.23M | 58.98M | -15K | -1.14M |
Operating Cash Flow | -64.13M | 14.76M | -30M | -18.13M |
Capital Expenditures | -9.58M | -2.86M | -3.76M | -2.31M |
Cash Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | -193.87M | -288.4M | -145.81M | n/a |
Sales Maturities Of Investments | 269.42M | 100.86M | 80.69M | n/a |
Other Investing Acitivies | n/a | n/a | 57K | n/a |
Investing Cash Flow | 65.96M | -190.4M | -68.83M | -2.31M |
Debt Repayment | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.55M | -1.72M | n/a | -151K |
Financial Cash Flow | -1.21M | 183.28M | n/a | 119.98M |
Net Cash Flow | 625K | 7.65M | -98.83M | 99.55M |
Free Cash Flow | -73.71M | 11.9M | -33.77M | -20.43M |
Adj. Free Cash Flow | -78.84M | 9.64M | -35.25M | -21.13M |
Maintenance CapEx | n/a | n/a | -1.12M | -445K |
Growth CapEx | -9.58M | -2.86M | -2.64M | -1.86M |
Owner Earnings | -64.13M | 14.76M | -31.12M | -18.57M |
Add to Watchlist
Select watchlists to add or remove AKTS